The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Liposomal amphotericin B is licensed for the treatment ... for use in neonates and premature infants. Amphotericin B lipid complex is licensed as a salvage treatment option in patients with ...

2 for conversion of amphotericin B into rationally designed analogs will facilitate the construction of an arsenal of new chemical probes to enable deeper understanding of the complex behavior of ...

parapsilosis Second most common isolated strain in children, central venous catheter or implanted devices, total parenteral nutrition - Amphotericin B lipid complex 5 mg/kg IDSA (2009) Stable ...